Beyond Diagnosis: Evolving Prostate Biopsy in the Era of Focal Therapy

por Dominguez-Escrig, J. L., McCracken, S. R. C., Greene, D.
Publicado 2011

A novel CRISPR-engineered prostate cancer cell line defines the AR-V transcriptome and identifies PARP inhibitor sensitivities

por Kounatidou, Evangelia, Nakjang, Sirintra, McCracken, Stuart R C, Dehm, Scott M, Robson, Craig N, Jones, Dominic, Gaughan, Luke
Publicado 2019

Evaluation of the fibroblast growth factor system as a potential target for therapy in human prostate cancer

por Gowardhan, B, Douglas, D A, Mathers, M E, McKie, A B, McCracken, S R C, Robson, C N, Leung, H Y
Publicado 2005

Regulation of the androgen receptor by SET9-mediated methylation

por Gaughan, Luke, Stockley, Jacqueline, Wang, Nan, McCracken, Stuart R.C., Treumann, Achim, Armstrong, Kelly, Shaheen, Fadhel, Watt, Kate, McEwan, Iain J., Wang, Chenguang, Pestell, Richard G., Robson, Craig N.
Publicado 2011

Regulation of the androgen receptor by SET9-mediated methylation

por Gaughan, Luke, Stockley, Jacqueline, Wang, Nan, McCracken, Stuart R. C., Treumann, Achim, Armstrong, Kelly, Shaheen, Fadhel, Watt, Kate, McEwan, Iain J., Wang, Chenguang, Pestell, Richard G., Robson, Craig N.
Publicado 2013

Comparison of the performances of the ADXBLADDER test and urinary cytology in the follow‐up of non‐muscle‐invasive bladder cancer: a blinded prospective multicentric study

por Gontero, Paulo, Montanari, Emanuele, Roupret, Morgan, Longo, Fabrizio, Stockley, Jacqueline, Kennedy, Ashleigh, Rodriguez, Oscar, McCracken, Stuart R.C., Dudderidge, Tim, Sieverink, Caroline, Vanié, Felicien, Allasia, Marco, Witjes, J. Alfred, Sylvester, Richard, Colombel, Marc, Palou, Juan
Publicado 2020

ERK5 signalling in prostate cancer promotes an invasive phenotype

por Ramsay, A K, McCracken, S R C, Soofi, M, Fleming, J, Yu, A X, Ahmad, I, Morland, R, Machesky, L, Nixon, C, Edwards, D R, Nuttall, R K, Seywright, M, Marquez, R, Keller, E, Leung, H Y
Publicado 2011